Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Coronary function testing during angiography boosts 1-year angina outcomes

Key clinical point: Stratifying nonobstructive coronary disease by invasive testing during angiography led to better patient management and improved outcomes.

Major finding: Patients managed by clinicians aware of the full diagnostic results had blood pressures that averaged 12/5 mm Hg below those of controls after 1 year.

Study details: CorMicA, a two-center, randomized study of 151 patients with stable angina and nonobstructive coronary disease.

Disclosures: Dr. Berry has been a speaker on behalf of Abbott Vascular, and he has received research funding from AstraZeneca, GlaxoSmithKline, HeartFlow, Novartis, and Siemens Healthcare. Dr. Reynolds had no disclosures.

Citation:

Ford TJ. AHA scientific sessions abstract.